Aspire-Lakewood Holdings, Inc. (ASBPW)
Aspire Biopharma Holdings, Inc. operates as a biotechnology enterprise primarily focused on innovative diagnostic approaches and molecular analysis. The company's core mission involves engineering remarkably precise testing tools for the identification of various illnesses, utilizing breakthroughs in genetic and biochemical science to serve the needs of the healthcare and life science sectors.
Sector: Pharmaceutical Preparations
Industry: Medical - Pharmaceuticals
Aspire Biopharma Holdings, Inc.
+15.91%$0.0153
Mkt Cap$21K
Float-
O/S1.4M
Inst Own-
SI0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$6K
Net Income-$24.48M
Total Assets$1.31M
Free Cash Flow-$4.92M
Debt & Equity
Total Debt$1.38M
Total Equity-$6.38M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
2-year cumulative
1:900Over cap
Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period
- 1:30Reverse splitMay 11, 202630 shares → 1
- 1:30Reverse splitMay 11, 202630 shares → 1
Balance Sheet Details
Assets$1.31M
Liabilities$7.69M
Accounts Receivable$0
Accounts Payable$1.01M
Inventory$253K
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Revenue | $6K | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - |
| Cost of Revenue | $6K | $0 | $0 | $0 | $0 |
| Gross Profit | -$116 | $0 | $0 | $0 | $0 |
| Gross Margin | -1.9% | - | - | - | - |
| Research and Development | $924K | $144K | $72K | $0 | $0 |
| Selling, General, and Administrative | $18.43M | $1.07M | $1.34M | $976K | $28K |
| Other | $0 | $0 | -$72K | $0 | -$2K |
| Total Operating Expenses | $19.35M | $1.21M | $1.34M | $976K | $25K |
| Operating Income (EBIT) | -$19.35M | -$1.21M | -$1.34M | -$976K | -$25K |
| Operating Margin | -312016.9% | - | - | - | - |
| Interest Expense | $8.53M | $98K | $9K | $0 | $0 |
| Interest Income | $0 | $549K | $5.81M | $4.32M | $0 |
| Other Income (Expense) | -$5.13M | -$98K | $5.8M | $4.32M | $5 |
| Income Before Tax (EBT) | -$24.48M | -$1.31M | $4.46M | $3.34M | -$25K |
| Income Tax Expense | $0 | $1K | $0 | $0 | $0 |
| Net Income | -$24.48M | -$1.31M | $4.46M | $3.34M | -$25K |
| Net Income Margin | -394725.1% | - | - | - | - |
| Supplementary Data | |||||
| EPS | -16.38 | -34.17 | 9.31 | 3.72 | -0.04 |
| Diluted EPS | -16.38 | -34.17 | 9.31 | 3.72 | -0.04 |
| Weighted Average OS | 1.49M | 38,339 | 479,478 | 898,437 | 682,812 |
| EBITDA | -$11.33M | -$1.21M | $5.81M | -$976K | $2K |
| EBITDA Margin | -182712.7% | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Assets | |||||
| Current Assets | |||||
| Cash and Cash Equivalents | $1M | $4K | $0 | $497K | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $1M | $4K | $0 | $497K | $0 |
| Accounts Receivable | $0 | $37K | $0 | $0 | $0 |
| Inventory | $253K | $0 | $0 | $0 | $0 |
| Other Current Assets | $55K | $108K | $81K | $600K | $293K |
| Total Current Assets | $1.31M | $148K | $81K | $1.1M | $293K |
| Long-Term Assets | |||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $6.67M | $19.9M | $299K | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $298.79M | $293K |
| Total Long-Term Assets | $0 | $6.67M | $19.9M | $299.08M | $293K |
| Other Assets | $0 | $0 | $0 | $0 | -$293K |
| Total Assets | $1.31M | $148K | $19.98M | $300.18M | $293K |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | $1.01M | $310K | $0 | $181K | $273 |
| Short-Term Debt | $1.38M | $1.27M | $12K | $28K | $239K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $80 | $0 |
| Other Current Liabilities | $4.84M | $111K | $391K | -$28K | $0 |
| Total Current Liabilities | $7.59M | $1.69M | $403K | $303K | $294K |
| Long-Term Liabilities | |||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $96K | $0 | $0 | $10.81M | $0 |
| Total Long-Term Liabilities | $96K | $0 | $0 | $10.81M | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $7.69M | $1.69M | $403K | $11.12M | $294K |
| Stockholders' Equity | |||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $353 | $69 | $19.9M | $299M | $718 |
| Retained Earnings | -$27.26M | -$2.78M | -$11.29M | -$9.94M | -$25K |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $20.88M | $1.24M | $10.96M | $0 | $24K |
| Total Equity | -$6.38M | -$1.54M | $19.58M | $289.07M | -$475 |
| Minority Interest | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $1.31M | $148K | $19.98M | $300.18M | $293K |
| Supplementary Data | |||||
| Total Debt | $1.38M | $1.27M | $12K | $28K | $239K |
| Net Debt | $381K | $1.26M | $12K | -$469K | $239K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Operating Activities | |||||
| Net Income | -$24.48M | -$1.31M | $4.46M | -$597K | -$28 |
| Depreciation & Amortization | $8.02M | $0 | $1.34M | $0 | $28K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $14.13M | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | |||||
| Accounts Receivable | $0 | -$37K | $0 | $400K | $0 |
| Inventory | -$253K | $0 | $0 | $0 | $0 |
| Accounts Payable | -$324K | $0 | $0 | $103K | $0 |
| Other Working Capital | $1.11M | $1.07M | $687K | -$49K | -$232 |
| Total Working Capital Change | $533K | $1.03M | $687K | $454K | -$232 |
| Other Non-Cash Items | -$3.13M | $11K | -$7.14M | $0 | -$28K |
| Net Cash from Operating | -$4.92M | -$265K | -$653K | -$143K | -$260 |
| Investing Activities | |||||
| Capital Expenditures | $0 | $0 | $0 | -$4.9M | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $13.78M | $0 | $0 | $0 |
| Other Investing Activities | $0 | -$13.78M | $284.92M | $0 | $0 |
| Net Cash from Investing | $0 | $0 | $284.92M | -$4.9M | $0 |
| Financing Activities | |||||
| Debt Repaid | - | - | - | - | - |
| Common Stock Issuance | $266K | $343K | $156K | $1M | $0 |
| Common Stock Repurchases | $0 | -$13.78M | -$284.92M | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$907K | $11.98M | $0 | $4.11M | $260 |
| Net Cash from Financing | $5.92M | $258K | -$284.76M | $4.85M | $260 |
| Forex Effect | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $1M | -$8K | -$497K | -$185K | $0 |
| Supplementary Data | |||||
| Operating Cash Flow | -$4.92M | -$265K | -$653K | -$143K | -$260 |
| Capital Expenditure | $0 | $0 | -$3 | -$4.9M | $0 |
| Free Cash Flow | -$4.92M | -$265K | -$653K | -$5.04M | -$260 |
| Cash at Beginning | $4K | $11K | $497K | $185K | $0 |
| Cash at End | $1M | $4K | $0 | $38 | $0 |